|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest earning deposits | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investment securities, at fair value (includes allowance for credit losses of $29,910 and $28,805, respectively) | ||||||||||||||||||||
| Investment securities held to maturity | ||||||||||||||||||||
| Loans held for sale (includes $5,510 and $2,745, respectively, at fair value) | ||||||||||||||||||||
| Loans receivable, PPP | ||||||||||||||||||||
| Loans and leases receivable | ||||||||||||||||||||
| Loans receivable, mortgage finance, at fair value | ||||||||||||||||||||
| Loans receivable, installment, at fair value | ||||||||||||||||||||
| Allowance for credit losses on loans and leases | ||||||||||||||||||||
| Total loans and leases receivable, net of allowance for credit losses on loans and leases | ||||||||||||||||||||
| FHLB, Federal Reserve Bank, and other restricted stock | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank premises and equipment, net | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Goodwill and other intangibles | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Demand, non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Subordinated debt | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, par value $1.00 per share; liquidation preference $25.00 per share; 100,000,000 shares authorized; no shares issued and outstanding as of December 31, 2025 and 5,700,000 shares issued and outstanding as of December 31, 2024 | ||||||||||||||||||||
| Common stock, par value $1.00 per share; 200,000,000 shares authorized; 36,484,767 and 36,188,920 shares issued as of June 30, 2026 and December 31, 2025; 33,772,598 and 34,191,223 shares outstanding as of June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net | ||||||||||||||||||||
| Treasury stock, at cost (2,712,169 and 1,997,697 shares as of June 30, 2026 and December 31, 2025) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Treasury stock (shares) | ||||||||||||||||||||
Loading...
